⌘K

Login Start Free

Home/Filings/4/0001831283-24-000011

4//SEC Filing

GIANAKAKOS ANASTASIOS 4

Accession 0001831283-24-000011

CIK 0001831283other

View on SEC.gov Company Profile

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:11 PM ET

Size

8.6 KB

Accession

0001831283-24-000011

Insider Transaction Report

Form 4

Period: 2024-02-15

GIANAKAKOS ANASTASIOS

Director

Transactions

Exercise/Conversion
Ordinary Shares
2024-02-15$2.52/sh+36,300$91,476→ 72,848 total
Tax Payment
Ordinary Shares
2024-02-15$4.76/sh−19,218$91,478→ 53,630 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-02-15−36,300→ 0 total
Exercise: $2.52Exp: 2032-06-23→ Ordinary Shares (36,300 underlying)

Holdings

Ordinary Shares
(indirect: By Trust)
309,623

Footnotes (1)

[F1]The shares underlying the option became exercisable in full on June 23, 2023.

Documents

1 file

4
wk-form4_1708463476.xmlPrimary
FORM 4

Issuer

LianBio

CIK 0001831283

Entity typeother

Related Parties

1

filerCIK 0001413822

Filing Metadata

Form type: 4
Filed: Feb 19, 7:00 PM ET
Accepted: Feb 20, 4:11 PM ET
Size: 8.6 KB

View on SEC.gov